Extragonadal Germ Cell Tumors
Extragonadal Germ Cell Tumors
TREATMENT READING
Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.
Not medical advice · Not a complete treatment or trial directory
Made by Triangle.
Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 9, 2024. Captured 2026-09-09.
Benign teratomas are treated with surgical excision only. These tumors are frequently very large, and the surgical procedure can be formidable.
This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 9, 2024. Captured 2026-09-09.
The diagnosis of seminoma requires that the serum alpha-fetoprotein be normal, with no other germ cells present. Management decisions in patients presenting with these tumors can be difficult.
As in testicular seminoma, these tumors are very radiosensitive. About 60% to 80% of patients will remain disease free after treatment with radiation therapy.[1] Craniospinal radiation therapy for intracranial germinomas (the intracranial counterpart of seminoma) is associated with relapse-free and overall survival rates of 90% to 95% at 5 years, respectively, as evidenced in the GER-GPO-MAKEI-86/89 trial, for example.[2][Level of evidence C1]
Sources: 1 · 2 · Level of evidence C1
Initial chemotherapy with regimens used in nonseminoma testicular cancer is also efficacious. Practically speaking, patients with localized relatively small tumors are usually treated initially with radiation therapy, while those with very bulky tumors or nonlocalized tumors are treated with etoposide-based and cisplatin-based chemotherapy regimens.
As in testicular seminoma, many patients will be left with a residual mass posttreatment. If the residual mass is smaller than 3.0 cm, most experts agree that observation is appropriate. In those with larger residual masses, some experts favor surgical excision while others favor observation.[3,4]
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 9, 2024. Captured 2026-09-09.
Patients with nonseminomas should receive chemotherapy at diagnosis. These patients tend to have a large tumor volume at diagnosis and are usually symptomatic. Initial debulking surgery is rarely useful. Many high-risk patients qualify for clinical trials. Standard therapy is generally four courses of BEP (bleomycin, etoposide, and cisplatin).[1,2]
A randomized study comparing four courses of BEP with four courses of VIP (etoposide, ifosfamide, and cisplatin) showed similar overall survival (OS) and time-to-treatment failure for the two regimens in patients with advanced disseminated germ cell tumors who had not received previous chemotherapy.[3,4][Level of evidence A1] Of the 304 patients in this study, 66 had extragonadal primary tumors. In this subset of patients, responses to the two regimens were similar. Hematologic toxic effects in OS were substantially worse with the VIP regimen than with the BEP regimen.
Sources: 3 · 4 · Level of evidence A1
Patients with a residual mass after chemotherapy may achieve long-term disease-free survival after postchemotherapy surgery with resection of all residual disease.[5][Level of evidence C2] Patients with nonseminomatous extragonadal germ cell tumors who relapse after front-line chemotherapy generally have poor prognoses with poor responses to salvage chemotherapy regimens, including autologous bone marrow transplant, that have had success for recurrent testicular cancer.[6-8] Such patients are candidates for studies of new approaches.
Sources: 5 · Level of evidence C2 · 6 · 8
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 9, 2024. Captured 2026-09-09.
Mediastinal nonseminomas have certain unique aspects. The tumors are more frequent in individuals with Klinefelter syndrome and are associated with a risk of subsequent development of hematologic neoplasia that is not treatment related.[9,10] Approximately 50% of patients with mediastinal nonseminomas will survive with appropriate management.[11] High risk is partially related to tumor bulk, chemotherapy resistance, and a predisposition to develop hematologic neoplasia and other nongerm cell malignancies. In an uncontrolled study, some patients with a postchemotherapy residual mediastinal mass achieved long-term disease-free survival after complete resection, even when serum tumor markers were elevated.[5][Level of evidence C2] Patient selection factors may play a role in these favorable outcomes.
Sources: 9 · 10 · 11 · 5 · Level of evidence C2
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 9, 2024. Captured 2026-09-09.
The prognosis of retroperitoneal nonseminoma is reasonably good and, similar to the situation with nodal metastasis from a testicular primary tumor, is related to tumor volume.
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 9, 2024. Captured 2026-09-09.
A randomized controlled trial compared conventional doses of salvage chemotherapy to high-dose chemotherapy with autologous marrow rescue in 263 patients with recurrent or refractory germ cell tumors. Of the 263 patients, 43 of whom had extragonadal primary tumors, more toxic effects and treatment-related deaths were seen in the high-dose arm, without any improvement in response rate or overall survival.[1][Level of evidence A1]
Sources: 1 · Level of evidence A1
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2025. Captured 2026-09-09.
The prognosis and treatment options depend on:
whether the tumor is nonseminoma or seminoma
the size of the tumor and where it is in the body
whether the tumor has spread to other parts of the body
the way the tumor responds to initial treatment
whether the tumor has just been diagnosed or has recurred (come back)
Sources: recurred
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2025. Captured 2026-09-09.
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2025. Captured 2026-09-09.
There are different types of treatment for patients with extragonadal germ cell tumors.
The following types of treatment are used:
The following types of treatment are used:
Radiation therapy
Chemotherapy
Surgery
New types of treatment are being tested in clinical trials.
New types of treatment are being tested in clinical trials.
High-dose chemotherapy with stem cell transplant
Treatment for extragonadal germ cell tumors may cause side effects.
Follow-up care may be needed.
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2025. Captured 2026-09-09.
Different types of treatments are available for extragonadal germ cell tumors. You and your cancer care team will work together to decide your treatment plan, which may include more than one type of treatment. Many factors will be considered, such as the tumor's prognostic group, your overall health, and your preferences. Your plan will include information about your cancer, the goals of treatment, your treatment options and the possible side effects, and the expected length of treatment.
Sources: extragonadal germ cell tumors
Talking with your cancer care team before treatment begins about what to expect will be helpful. You’ll want to learn what you need to do before treatment begins, how you’ll feel while going through it, and what kind of help you will need. To learn more, visit Questions to Ask Your Doctor about Treatment.
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2025. Captured 2026-09-09.
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2025. Captured 2026-09-09.
Radiation therapy uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. External radiation therapy uses a machine outside the body to send radiation toward the area of the body with cancer. External radiation therapy is used to treat seminoma.
Sources: Radiation therapy · x-rays · radiation · External radiation therapy · seminoma
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2025. Captured 2026-09-09.
Chemotherapy (also called chemo) uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing.
Chemotherapy for extragonadal germ cell tumors is usually systemic, meaning it is injected into a vein or given by mouth. When given this way, the drugs enter the bloodstream to reach cancer cells throughout the body.
Chemotherapy drugs used to treat extragonadal germ cell tumors may include:
bleomycin
Sources: bleomycin
carboplatin
Sources: carboplatin
cisplatin
Sources: cisplatin
etoposide
Sources: etoposide
ifosfamide
Sources: ifosfamide
Combinations of these drugs may be used. Other chemotherapy drugs not listed here may also be used.
Learn more about how chemotherapy works, how it is given, common side effects, and more at Chemotherapy to Treat Cancer and Chemotherapy and You: Support for People With Cancer.
Sources: Chemotherapy to Treat Cancer · Chemotherapy and You: Support for People With Cancer
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2025. Captured 2026-09-09.
If you have benign tumors or tumor remaining after chemotherapy or radiation therapy, surgery may be needed.
Sources: benign tumors
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2025. Captured 2026-09-09.
For some people, joining a clinical trial may be an option. There are different types of clinical trials for people with cancer. For example, a treatment trial tests new treatments or new ways of using current treatments. Supportive care and palliative care trials look at ways to improve quality of life, especially for those who have side effects from cancer and its treatment.
You can use the clinical trial search to find NCI-supported cancer clinical trials accepting participants. The search allows you to filter trials based on the type of cancer, your age, and where the trials are being done. Clinical trials supported by other organizations can be found on the ClinicalTrials.gov website.
Sources: clinical trial search · ClinicalTrials.gov
Learn more about clinical trials, including how to find and join one, at Clinical Trials Information for Patients and Caregivers.
Sources: Clinical Trials Information for Patients and Caregivers
This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.
Sources: NCI website
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2025. Captured 2026-09-09.
High doses of chemotherapy are given to kill cancer cells. Healthy cells, including blood-forming cells, are also destroyed by the cancer treatment. Stem cell transplant is a treatment to replace the blood-forming cells. Stem cells (immature blood cells) are removed from the blood or bone marrow of the patient or a donor and are frozen and stored. After the patient completes chemotherapy, the stored stem cells are thawed and given back to the patient through an infusion. These reinfused stem cells grow into (and restore) the body's blood cells.
Sources: Stem cell transplant · blood · bone marrow · donor · infusion
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2025. Captured 2026-09-09.
For information about side effects caused by treatment for cancer, visit our Side Effects page.
Sources: side effects · Side Effects
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2025. Captured 2026-09-09.
As you go through treatment, you will have follow-up tests or check-ups. Some tests that were done to diagnose or stage the cancer may be repeated to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.
Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back).
After initial treatment for extragonadal germ cell tumors, your blood levels of AFP and other tumor markers will continue to be checked to find out how well the treatment is working.
Sources: AFP · tumor markers
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2025. Captured 2026-09-09.
Learn more about this treatment in the Treatment Option Overview.
Sources: Treatment Option Overview
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Sources: clinical trial search · General information
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2025. Captured 2026-09-09.
Treatment of seminoma extragonadal germ cell tumors may include:
Sources: seminoma · extragonadal germ cell tumors
Radiation therapy for small tumors in one area, followed by watchful waiting if there is tumor remaining after treatment.
Sources: Radiation therapy · watchful waiting
Chemotherapy for larger tumors or tumors that have spread. If a tumor smaller than 3 centimeters remains after chemotherapy, watchful waiting follows. If a larger tumor remains after treatment, surgery or watchful waiting follow.
Sources: Chemotherapy · centimeters
Learn more about these treatments in the Treatment Option Overview.
Sources: Treatment Option Overview
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Sources: clinical trial search · General information
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2025. Captured 2026-09-09.
Treatment of nonseminoma extragonadal germ cell tumors may include:
Sources: nonseminoma · extragonadal germ cell tumors
Combination chemotherapy followed by surgery to remove any remaining tumor.
Sources: Combination chemotherapy
Learn more about these treatments in the Treatment Option Overview.
Sources: Treatment Option Overview
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Sources: clinical trial search · General information
Source: Extragonadal Germ Cell Tumors Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: February 19, 2025. Captured 2026-09-09.
Treatment of extragonadal germ cell tumors that are recurrent (come back after being treated) or refractory (do not get better during treatment) may include:
Sources: extragonadal germ cell tumors
chemotherapy
Sources: chemotherapy
a clinical trial of high-dose chemotherapy with stem cell transplant
Sources: clinical trial · high-dose chemotherapy · stem cell transplant
Learn more about these treatments in the Treatment Option Overview.
Sources: Treatment Option Overview
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Sources: clinical trial search · General information
Extragonadal Germ Cell Tumors
Treatment of Recurrent or Refractory Extragonadal Germ Cell Tumors